Allegiance Financial Group Advisory Services »

BioMarin Pharmaceutical shares owned by Allegiance Financial Group Advisory Services

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Allegiance Financial Group Advisory Services from 13F filings

Historical chart of Allegiance Financial Group Advisory Services investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Allegiance Financial Group Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Allegiance Financial Group Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $204k 3.8k 54.16
2025-03-31 $217k 3.1k 70.69

More positions owned by Allegiance Financial Group Advisory Services

Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
American Centy Etf Tr Avantis Core Fi (AVIG)
Dimensional Etf Trust Short Duration F (DFSD)
Microsoft Corporation (MSFT)
American Centy Etf Tr International Lr (AVIV)
Ishares Tr Core Msci Intl (IDEV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Broad Usd High (USHY)
American Centy Etf Tr Real Estate Etf (AVRE)
American Centy Etf Tr Emerging Mkt Val (AVES)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Allegiance Financial Group Advisory Services

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical